Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance

被引:77
作者
Chou, Sunwen [1 ,2 ]
机构
[1] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA
[2] Dept Vet Affairs Med Ctr, Portland, OR USA
基金
美国国家卫生研究院;
关键词
STEM-CELL TRANSPLANTATION; UL97; KINASE; IN-VITRO; GANCICLOVIR RESISTANCE; PHENOTYPIC CHARACTERIZATION; FOSCARNET RESISTANCE; TERMINASE COMPLEX; PROTEIN-KINASE; MUTATIONS; LETERMOVIR;
D O I
10.1016/j.antiviral.2020.104711
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytomegalovirus (CMV) drug resistance mutation maps are updated with recent information for polymerase inhibitors, the terminase inhibitor letermovir and the UL97 kinase inhibitor maribavir. Newly mapped mutations and their phenotypes provide more detail on cross-resistance properties and suggest the need to expand the CMV gene regions covered in diagnostic testing. Next-generation deep sequencing technology offers a more sensitive, higher resolution view of emerging antiviral resistance and is recommended for use in clinical trials. Issues of standardization and diagnostic utility in comparison with traditional Sanger sequencing remain unresolved. Quality control is important for the accurate and reproducible detection of mutant viral populations in clinical specimens.
引用
收藏
页数:10
相关论文
共 92 条
  • [1] Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss
    Andrei, Graciela
    Van Loon, Elisabet
    Lerut, Evelyne
    Victoor, Jasper
    Meijers, Bjorn
    Bammens, Bert
    Sprangers, Ben
    Gillemot, Sarah
    Fiten, Pierre
    Opdenakker, Ghislain
    Lagrou, Katrien
    Kuypers, Dirk
    Snoeck, Robert
    Naesens, Maarten
    [J]. ANTIVIRAL RESEARCH, 2019, 168 : 203 - 209
  • [2] [Anonymous], [No title captured]
  • [3] Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS
    Baldanti, F
    Underwood, MR
    Stanat, SC
    Biron, KK
    Chou, SW
    Sarasini, A
    Silini, E
    Gerna, G
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1390 - 1395
  • [4] Antagonistic Relationship between Human Cytomegalovirus pUL27 and pUL97 Activities during Infection
    Bigley, Tarin M.
    Reitsma, Justin M.
    Terhune, Scott S.
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (20) : 10230 - 10246
  • [5] Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action
    Biron, KK
    Harvey, RJ
    Chamberlain, SC
    Good, SS
    Smith, AA
    Davis, MG
    Talarico, CL
    Miller, WH
    Ferris, R
    Dornsife, RE
    Stanat, SC
    Drach, JC
    Townsend, LB
    Koszalka, GW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2365 - 2372
  • [6] A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products
    Buerger, I
    Reefschlaeger, J
    Bender, W
    Eckenberg, P
    Popp, A
    Weber, O
    Graeper, S
    Klenk, HD
    Ruebsamen-Waigmann, H
    Hallenberger, S
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (19) : 9077 - 9086
  • [7] Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art
    Campos, Ana Bela
    Ribeiro, Joana
    Boutolleau, David
    Sousa, Hugo
    [J]. REVIEWS IN MEDICAL VIROLOGY, 2016, 26 (03) : 161 - 182
  • [8] Champier G, 2008, ANTIVIR THER, V13, P643
  • [9] Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials
    Chemaly, Roy F.
    Chou, Sunwen
    Einsele, Hermann
    Griffiths, Paul
    Avery, Robin
    Razonable, Raymund R.
    Mullane, Kathleen M.
    Kotton, Camille
    Lundgren, Jens
    Komatsu, Takashi E.
    Lischka, Peter
    Josephson, Filip
    Douglas, Cameron M.
    Umeh, Obi
    Miller, Veronica
    Ljungman, Per
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (08) : 1420 - 1426
  • [10] Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation
    Chemaly, Roy F.
    Ullmann, Andrew J.
    Stoelben, Susanne
    Richard, Marie Paule
    Bornhaeuser, Martin
    Groth, Christoph
    Einsele, Hermann
    Silverman, Margarida
    Mullane, Kathleen M.
    Brown, Janice
    Nowak, Horst
    Koelling, Katrin
    Stobernack, Hans P.
    Lischka, Peter
    Zimmermann, Holger
    Ruebsamen-Schaeff, Helga
    Champlin, Richard E.
    Ehninger, Gerhard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) : 1781 - 1789